- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/275 - NitrilesIsonitriles
Détention brevets de la classe A61K 31/275
Brevets de cette classe: 419
Historique des publications depuis 10 ans
|
33
|
31
|
22
|
29
|
20
|
13
|
22
|
25
|
23
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Olatec Therapeutics, Inc. | 61 |
34 |
| The Procter & Gamble Company | 21854 |
10 |
| The Cleveland Clinic Foundation | 1579 |
10 |
| Milestone Pharmaceuticals Inc. | 26 |
10 |
| Sergeant's Pet Care Products, LLC | 126 |
9 |
| The Regents of the University of California | 20690 |
8 |
| Navitor Pharmaceuticals, Inc. | 35 |
7 |
| Olatec Therapeutics LLC | 26 |
7 |
| BioResponse, L.L.C. | 27 |
6 |
| Kyoto University | 2897 |
6 |
| DSM IP Assets B.V. | 5381 |
5 |
| Board of Regents, The University of Texas System | 6079 |
5 |
| The Regents of the University of Michigan | 4964 |
5 |
| NeuroDerm, Ltd. | 144 |
4 |
| NoNO Inc. | 68 |
4 |
| Pitney Pharmaceuticals Pty Limited | 19 |
4 |
| Sanofi-Aventis U.S. LLC | 52 |
4 |
| H.B. Fuller Medical Adhesive Technologies, LLC | 54 |
4 |
| Glaxosmithkline LLC | 528 |
3 |
| BASF SE | 21292 |
3 |
| Autres propriétaires | 271 |